No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
74 |
4. Check minimum number of eventsNone |
74 |
5. Include endpointsNone |
74 |
6. Filter based on genotype QC (FinnGen only) |
74 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Tuberous sclerosis 1
based on the number of shared cases.
Similar with more cases:
- Phakomatoses, not elsewhere classified
- Other congenital malformations
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 74 | 49 | 25 |
| Unadjusted period prevalence (%) | 0.01 | 0.02 | 0.01 |
| Median age at first event (years) | 28.23 | 30.82 | 23.15 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3024561) Albumin [Mass/volume] in Serum or Plasma
41
178
3.92
7.82
5.2
7.0
g/l
37.7
37.4
0.13
36
173
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
41
192
3.55
6.73
4.6
3.9
—
—
—
0
0
(3002256) Pathology report gross observation
21
66
4.05
6.17
1.4
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
47
249
3.43
6.16
11.7
10.4
mmol/l
1.2
1.2
0.14
42
217
(3018418) pH of Serum or Plasma
32
135
3.41
6.08
4.6
4.4
ph
7.4
7.4
—
8
22
(4035726)
15
38
4.70
5.77
1.1
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
6
14.72
5.21
2.1
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
6
14.72
5.21
1.6
1.5
nmol/l
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
8
6
14.72
5.21
2.1
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
19
63
3.71
5.12
5.6
17.5
mmol/l
23.2
24.7
1.55
19
63
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
38
4.31
4.91
3.8
2.9
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
7
12.60
4.91
2.1
1.6
nmol/l
0.6
0.5
—
8
7
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
23
90
3.26
4.79
3.5
3.2
e6/l
2.3
2.3
0.00
16
53
(3032080) INR in Blood by Coagulation assay
33
160
2.92
4.74
4.8
4.7
inr
1.0
1.2
2.22
13
48
(36304419) Bacteria [Presence] in Urine
33
161
2.89
4.68
4.2
3.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
13
35
4.29
4.60
5.2
8.3
mmol/l
-0.1
1.4
—
8
28
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
23
98
2.95
4.09
3.4
2.9
e6/l
0.8
0.9
0.04
18
62
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
12
34
4.02
3.95
2.1
1.4
ml/min/173m2
90.7
62.4
—
6
11
(3018677) aPTT in Platelet poor plasma by Coagulation assay
20
83
2.93
3.70
2.7
11.7
s
29.7
30.7
0.36
20
83
(3044889) 12 lead EKG panel
49
327
2.48
3.33
3.2
2.9
—
—
—
0
0
(3015736) pH of Urine
38
234
2.28
3.02
3.7
3.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
6
9
7.13
2.92
1.8
3.4
mmol/l
1.6
1.7
—
6
9
(3023368) Bacteria identified in Blood by Culture
21
101
2.51
2.88
4.2
5.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
159
0.27
2.88
4.8
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
34
204
2.23
2.83
1.9
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
54
393
2.38
2.79
4.6
4.1
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
6
10
6.41
2.75
2.0
6.1
kpa
4.5
5.2
—
6
10
(3027315) Oxygen [Partial pressure] in Blood
6
10
6.41
2.75
2.0
6.1
kpa
9.6
10.0
—
6
10
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
26
146
2.20
2.49
2.5
3.3
ng/l
14.9
44.4
0.88
14
82
(3019550) Sodium [Moles/volume] in Serum or Plasma
68
578
3.17
2.41
20.8
12.5
mmol/l
139.2
139.7
0.69
68
563
(3000991) Gas panel - Venous blood
15
67
2.55
2.36
4.5
11.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
41
281
2.03
2.29
4.1
3.6
estimate
0.0
0.0
—
8
55
(3013826) Glucose [Moles/volume] in Serum or Plasma
43
301
2.02
2.25
5.4
6.2
mmol/l
5.8
6.4
1.91
43
274
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
62
500
2.48
2.22
13.1
8.6
ml/min/173m2
96.1
95.5
0.06
55
390
(3019060) Gas panel - Arterial blood
7
19
3.95
2.21
5.4
5.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
7
19
3.95
2.21
7.4
11.8
%
94.2
95.7
—
7
19
(3044640) Blood type and Crossmatch panel - Blood
27
163
2.03
2.11
2.6
3.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
10
5.27
2.10
2.4
4.0
e9/l
3.7
4.0
—
5
10
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
10
5.27
2.10
2.4
4.4
%
56.8
53.5
—
5
10
(3021601) Nitrite [Presence] in Urine by Test strip
41
287
1.96
2.10
5.8
5.0
estimate
0.0
0.0
—
10
56
(3021589) Normoblasts [#/volume] in Blood
42
297
1.96
2.08
10.1
12.8
e9/l
0.0
0.0
0.00
35
237
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
21
3.57
2.02
7.4
10.9
%
1.1
1.1
—
7
21
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
21
3.57
2.02
7.4
10.9
%
0.5
0.7
—
7
21
(3023103) Potassium [Moles/volume] in Serum or Plasma
67
578
2.68
1.99
20.5
12.5
mmol/l
4.0
3.9
0.96
67
562
(3009261) Glucose [Presence] in Urine by Test strip
41
291
1.92
1.98
4.1
3.5
estimate
0.0
0.0
—
10
51
(3008898) HLA-B27 [Presence]
0
51
0.00
1.98
0.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
24
142
2.02
1.96
4.3
3.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
32
216
1.85
1.75
6.5
11.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
11
210
0.44
1.73
2.7
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
13
63
2.29
1.72
1.5
2.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
26
2.86
1.62
1.0
1.4
—
—
—
0
0
(3012544) pH of Venous blood
14
74
2.10
1.51
3.8
11.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
5
16
3.27
1.46
5.6
11.2
mmol/l
23.2
24.5
—
5
16
(40758558) Short blood count panel - Blood
26
173
1.78
1.45
4.4
12.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
22
140
1.81
1.41
4.0
4.1
estimate
0.0
0.0
—
10
54
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
119
0.38
1.40
4.8
1.6
—
—
—
0
0
(3020891) Body temperature
5
17
3.08
1.38
6.2
7.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
17
3.08
1.38
7.8
5.6
%
53.3
61.5
—
5
17
(3050129) First trimester maternal screen panel - Serum or Plasma
0
41
0.00
1.36
0.0
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
34
250
1.67
1.31
4.3
4.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
22
144
1.75
1.28
2.9
2.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
63
551
1.96
1.23
16.3
16.1
%
13.3
13.2
0.25
63
543
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
36
0.00
1.17
0.0
1.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
69
632
2.36
1.12
17.9
11.7
umol/l
73.8
68.4
0.33
69
632
(40761536) Microorganisms panel - Urine sediment
9
48
1.99
1.05
4.8
4.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
11
61
1.94
1.05
6.5
9.5
mmol/l
1.0
1.0
—
6
46
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
29
0.00
1.00
0.0
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
67
610
2.04
0.99
16.1
12.3
mg/l
17.6
20.5
0.56
59
429
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
18
122
1.63
0.91
2.8
3.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
8
43
1.96
0.91
1.1
2.3
u/l
—
281.6
—
0
11
(3013115) Eosinophils [#/volume] in Blood
41
336
1.49
0.89
6.0
10.8
e9/l
0.2
0.2
0.34
34
288
(3042936) Bacteria identified in Isolate by Culture
10
57
1.87
0.88
4.2
2.5
—
—
—
0
0
(3013512) EKG study
16
106
1.65
0.88
2.3
3.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
11
66
1.78
0.84
1.6
4.7
ng/l
7.4
292.0
—
5
36
(3013650) Neutrophils [#/volume] in Blood by Automated count
44
369
1.47
0.83
9.0
13.3
e9/l
4.1
3.7
0.45
39
319
(4010399)
6
33
1.89
0.81
2.2
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
25
0.00
0.80
0.0
2.2
—
3.0
—
0
15
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
6
107
0.52
0.80
1.3
1.3
—
31.0
—
0
36
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
26
0.00
0.80
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
26
0.00
0.80
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
26
0.00
0.80
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
26
0.00
0.80
0.0
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
21
153
1.52
0.79
1.9
1.5
pmol/l
98.4
101.3
0.11
11
76
(3022313) Gas panel - Capillary blood
9
54
1.76
0.78
6.3
9.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
39
323
1.44
0.77
6.2
10.3
e9/l
0.6
0.5
0.76
33
276
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
24
2.16
0.76
1.8
2.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
39
324
1.43
0.75
6.2
10.3
e9/l
0.0
0.0
0.29
33
278
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
28
1.84
0.67
1.0
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
28
1.84
0.67
3.2
9.1
g/l
129.8
127.9
—
5
28
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
26
205
1.41
0.65
4.1
3.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
29
1.78
0.65
1.8
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
49
1.71
0.65
1.4
1.2
—
—
—
0
0
(3000492) Spirometry study
8
52
1.60
0.62
1.1
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
39
332
1.37
0.62
6.3
10.1
e9/l
1.8
2.1
1.00
33
290
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
21
0.00
0.61
0.0
2.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
21
0.00
0.61
0.0
3.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
22
0.00
0.60
0.0
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
22
0.00
0.60
0.0
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
22
0.00
0.60
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
22
0.00
0.60
0.0
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
20
153
1.42
0.58
3.3
3.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
6
36
1.72
0.58
5.0
3.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
15
196
0.71
0.51
1.6
1.6
g/l
1.5
1.9
—
8
110
(3019832) Treponema pallidum Ab [Presence] in Serum
9
129
0.66
0.48
1.1
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
8
57
1.45
0.44
10.0
5.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
8
57
1.45
0.44
1.5
2.7
u/l
15.6
28.9
—
8
49
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
15
0.00
0.41
0.0
4.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.7
—
7.3
—
0
9
(3019225) pH of Specimen
5
34
1.50
0.41
18.8
6.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
9
65
1.44
0.41
1.1
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.3
—
15.9
—
0
6
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
1.5
—
0
5
(3005322) IgE [Units/volume] in Serum or Plasma
7
53
1.35
0.32
1.0
1.4
u/ml
138.7
106.7
—
7
47
(3009542) Hematocrit [Volume Fraction] of Blood
64
611
1.35
0.31
13.2
14.0
%
39.9
40.7
1.03
54
515
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
7
55
1.30
0.31
8.6
9.7
mmol/l
23.5
24.2
—
7
55
(3003694) ABO and Rh group [Type] in Blood
22
190
1.22
0.27
1.5
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
5
38
1.34
0.24
3.6
2.2
nmol/l
19.3
12.1
—
5
33
(1761868) Lipid panel - Serum or Plasma
17
197
0.82
0.23
3.9
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
16
136
1.23
0.22
1.4
1.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
11
0.00
0.21
0.0
1.7
—
8.0
—
0
5
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
10
0.00
0.21
0.0
16.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
12
0.00
0.21
0.0
3.7
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
0
12
0.00
0.21
0.0
4.2
—
328.6
—
0
7
(3019230) Fractional oxyhemoglobin in Venous blood
0
12
0.00
0.21
0.0
14.4
—
69.8
—
0
12
(3049717) Cytology report of Urine Cyto stain
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
12
0.00
0.21
0.0
3.7
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.3
—
5.0
—
0
7
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
55
568
0.88
0.13
3.8
3.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
6
53
1.14
0.09
1.5
8.7
u/l
242.2
233.7
—
6
53
(40768797) Stomach Pathology biopsy report
6
54
1.12
0.09
1.0
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
6
58
1.04
0.08
1.8
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
61
0.81
0.08
3.4
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
84
0.82
0.07
1.0
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
86
1.05
0.07
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
152
1.07
0.02
1.1
2.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
22
212
1.05
0.02
1.8
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
116
1.04
0.00
1.8
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
14
144
0.97
0.00
4.1
6.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
166
1.03
0.00
1.1
2.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
64
0.93
0.00
4.3
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
4.1
—
0
5
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
6.5
—
0
5
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
4.0
—
0
5
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
19.4
—
0.6
—
0
5
(4062490)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
64
0.93
0.00
4.0
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
13.4
—
0
5
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
5
0.00
0.00
0.0
1.0
—
13.0
—
0
5
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
137.4
—
0
5
(3021788) Differential panel - Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
9.2
—
0.7
—
0
5
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
5.7
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
108.2
—
0
5
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
9.3
—
0
5
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
691.3
—
0
6
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
64
0.93
0.00
3.5
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
37.0
—
0
6
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
22.9
—
11.6
—
0
7
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4094501)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
50
1.00
0.00
2.8
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7
79
0.87
0.00
2.0
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
64
0.93
0.00
4.0
1.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.3
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_TUBEROUS_SCLEROSIS – Tuberous sclerosis 1
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).